1000-1130 |
Localized PCa• Pros and cons of MRI fusion biopsy (20’)
|
1130-1230 |
HORMONE-SENSITIVE PCa• The role of LHRH antagonists (20’) • Novel antiandrogens in PCa M0 (20’) • Chemo-hormone treatment (20’)
|
1230-1300 |
LIGHT LUNCH BREAK
|
1300-1500 |
CASTRATION RESISTANT PCa• Diagnosis and management of CRPC M0 (20’) |